BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 11, 2010
View Archived Issues
PTC-299/aromatase inhibitor combinations deemed feasible in breast cancer trial
Read More
Debio-0719 suppresses metastasis in mouse models of breast cancer
Read More
PP-9706642 shows promise as a prophylactic/therapeutic agent for HSV-2 infection
Read More
University of Connecticut claims new cannabinoid CB1 receptor antagonists
Read More
Apogee Biotechnology discovers new sphingosine kinase inhibitors
Read More
Taiho Pharma claims new H-PGDS inhibitors
Read More
French scientists present new inhibitors of CDK1, CDK5 activator 1 and/or GSK-3
Read More
Targacept reports clinical data on AZD-1446 in ADHD and AD
Read More
StemCells advances phase I trial of HuCNS-SC cells in Pelizaeus-Merzbacher disease
Read More
MD Anderson Cancer Center investigates antitumor potential of CG-100649
Read More
Adeona Pharma advances CopperProof-2 trial of Zinthionein
Read More
Tasocitinib meets primary endpoint in phase II psoriasis trial
Read More
VentiRx reports clinical data on VTX-1463 in allergic rhinitis
Read More
Neuronex is launched to develop drugs for CNS diseases
Read More
Onyx Pharma delays NDA submission for carfilzomib
Read More
NephRx provides update on new peptides, NX-001 and NX-002
Read More
Biotron begins phase II trial of BIT-225 in hepatitis C
Read More
Amylin Pharma to use Affibody's Albumod platform under new license agreement
Read More
New inhibitors of beta-secretase 1 disclosed by Medivir
Read More
Novel tachykinin NK3 receptor antagonists claimed by Roche
Read More
AGI-101 improves postsurgery survival in high-risk melanoma
Read More
Abbott to withdraw obesity drug Meridia from U.S. market
Read More
Bayer's contraceptive Qlaira approved in E.U. to treat heavy menstrual bleeding
Read More
Merck KGaA to appeal CHMP's opinion on cladribine tablets in MS
Read More
Recordati and Almirall launch silodosin for treatment of BPH symptoms in Spain
Read More